HCW Biologics Inc. financial data

Symbol
HCWB on Nasdaq
Location
2929 N Commerce Pkwy, Miramar, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10.9 % -51.7%
Debt-to-equity -734 % -141%
Return On Equity 276 %
Return On Assets -43.5 % +67.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.7M shares -92.9%
Entity Public Float 12.8M USD -70.1%
Common Stock, Value, Issued 262 USD -93.1%
Weighted Average Number of Shares Outstanding, Basic 2.26M shares +139%
Weighted Average Number of Shares Outstanding, Diluted 2.26M shares +139%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 338K USD -85.7%
Research and Development Expense 5.16M USD -31%
General and Administrative Expense 8.25M USD +54.1%
Operating Income (Loss) -11.9M USD +67.9%
Nonoperating Income (Expense) 0 USD
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -12.1M USD +67.7%
Earnings Per Share, Basic 10 USD/shares +51.1%
Earnings Per Share, Diluted 10 USD/shares +51.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.1M USD +9.89%
Other Assets, Current 250K USD +184%
Assets, Current 1.59M USD -24.1%
Property, Plant and Equipment, Net 22.5M USD -1.45%
Operating Lease, Right-of-Use Asset 28.1K USD -85.3%
Other Assets, Noncurrent 28.5K USD 0%
Assets 25.4M USD -4.18%
Accounts Payable, Current 19M USD -16.3%
Liabilities, Current 26.9M USD -10.7%
Deferred Income Tax Liabilities, Net 40.9K USD -72.2%
Operating Lease, Liability, Noncurrent 7.48K USD -94.6%
Liabilities 27.6M USD -24.6%
Retained Earnings (Accumulated Deficit) -109M USD -12.4%
Stockholders' Equity Attributable to Parent -2.11M USD +78.9%
Liabilities and Equity 25.4M USD -4.18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.51M USD +2.5%
Net Cash Provided by (Used in) Financing Activities -53.1K USD -101%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 2.62M shares -93.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.57M USD -829%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.1M USD +9.89%
Interest Paid, Excluding Capitalized Interest, Operating Activities 244K USD
Deferred Tax Assets, Valuation Allowance 26.2M USD +42.7%
Deferred Tax Assets, Gross 26.3M USD +41.8%
Operating Lease, Liability 153K USD -50%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 343K USD
Property, Plant and Equipment, Gross 26.6M USD +13.2%
Operating Lease, Liability, Current 28.5K USD -84%
Lessee, Operating Lease, Liability, to be Paid, Year Two 49.3K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 294K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Operating Lease, Payments 28.8K USD -31.9%
Additional Paid in Capital 107M USD +22.8%
Depreciation, Depletion and Amortization 419K USD +72.1%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 28.7K USD -83.3%
Operating Leases, Future Minimum Payments Due 28.7K USD -85.7%
Interest Expense 854K USD +121%